Values First Advisors’s Astera Labs ALAB Stock Holding History

Values First Advisors’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$319K	Buy	+897	New	+$289K	0.15%	142

Other funds holding ALAB

Salem Investment Counselors Winston Salem, North Carolina $4.01B AUM 48.23% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Park Avenue Securities New York $16.4B AUM 18.52% 1-Year Est. Return

MLCM

M & L Capital Management London, United Kingdom $482M AUM 107.4% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Renaissance Capital Stamford, Connecticut $145M AUM 53.16% 1-Year Est. Return

EULAV Asset Management Sarasota, Florida $2.77B AUM 18.47% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Values First Advisors's ALAB Position: Q3 2026 in Review

Values First Advisors opened a new position in Astera Labs (ALAB) in Q3 2026: 897 shares worth $319K. The stake represents 0.15% of the portfolio and ranks #142 among its holdings.

224 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

Values First Advisors held 897 shares of Astera Labs worth $319K as of Q3 2026.
Astera Labs was a new Values First Advisors position in Q3 2026.
Astera Labs made up 0.15% of Values First Advisors's portfolio in Q3 2026, its #142 holding.
224 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Values First Advisors's 13F filing for Q3 2026, filed 23 Oct 2026.